Simultaneous Occurrence of Gastric Antral Vascular Ectasia and Protein-losing Enteropathy in Chronic Graft-versus-host Disease
Overview
Authors
Affiliations
Gastric antral vascular ectasia (GAVE) leading to upper gastrointestinal bleeding is a heterogeneous disorder that is not commonly recognized in hematopoietic stem cell transplantation (HSCT). Protein-losing enteropathy (PLE) is noted as another gastrointestinal complication in the context of chronic graft-versus-host disease (GVHD) after HSCT. The possibility of a relationship between these two distinct gastrointestinal disorders, however, remains obscure. A 6-year-old boy with acute myelogenous leukemia developed severe hematemesis 4 months after myeloablative HSCT from a human leukocyte antigen-matched sibling donor. The diagnosis of GAVE was made by upper endoscopy and histological examination. The patient simultaneously developed frequent diarrhea and significant hypoproteinemia, consistent with a diagnosis of PLE. This co-occurrence of GAVE and PLE against a background of chronic GVHD was successfully treated with cyclosporin A and prednisolone. To our knowledge, this is the first report of GAVE concurrent with PLE following HSCT. The possible association of GAVE and PLE in chronic GVHD is discussed.
Sugishita Y, Yamamoto S, Kaneko R, Okamoto N, Koganesawa M, Fujita S Blood Cell Ther. 2023; 2(1):9-11.
PMID: 37969694 PMC: 10645482. DOI: 10.31547/bct-2018-007.
Grant M, Horwitz M Case Rep Transplant. 2018; 2018:2376483.
PMID: 29721346 PMC: 5867646. DOI: 10.1155/2018/2376483.